Guo-Ming Chen

No ORCID on file · 1 paper in corpus
2020
·doi:10.21203/rs.2.13766/v4

Abstract Background: We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer. Methods: We systematically reviewed adjuvant random…